Suppr超能文献

病毒载量检测不出时,有多可靠?

How reliable is an undetectable viral load?

机构信息

Division of Clinical Epidemiology, University Hospital Geneva, Geneva, Switzerland.

出版信息

HIV Med. 2009 Sep;10(8):470-6. doi: 10.1111/j.1468-1293.2009.00714.x. Epub 2009 May 6.

Abstract

OBJECTIVES

An article by the Swiss AIDS Commission states that patients with stably suppressed viraemia [i.e. several successive HIV-1 RNA plasma concentrations (viral loads, VL) below the limits of detection during 6 months or more of highly active antiretroviral therapy (HAART)] are unlikely to be infectious. Questions then arise: how reliable is the undetectability of the VL, given the history of measures? What factors determine reliability?

METHODS

We assessed the probability (henceforth termed reliability) that the n+1 VL would exceed 50 or 1000 HIV-1 RNA copies/mL when the nth one had been <50 copies/mL in 6168 patients of the Swiss HIV Cohort Study who were continuing to take HAART between 2003 and 2007. General estimating equations were used to analyse potential factors of reliability.

RESULTS

With a cut-off at 50 copies/mL, reliability was 84.5% (n=1), increasing to 94.5% (n=5). Compliance, the current type of HAART and the first antiretroviral therapy (ART) received (HAART or not) were predictive factors of reliability. With a cut-off at 1000 copies/mL, reliability was 97.5% (n=1), increasing to 99.1% (n=4). Chart review revealed that patients had stopped their treatment, admitted to major problems with compliance or were taking non-HAART ART in 72.2% of these cases. Viral escape caused by resistance was found in 5.6%. No explanation was found in the charts of 22.2% of cases.

CONCLUSIONS

After several successive VLs at <50 copies/mL, reliability reaches approximately 94% with a cut-off of 50 copies/mL and approximately 99% with a cut-off at 1000 copies/mL. Compliance is the most important factor predicting reliability.

摘要

目的

瑞士艾滋病委员会的一篇文章指出,病毒血症得到稳定抑制的患者(即经过 6 个月或更长时间的高效抗逆转录病毒治疗(HAART)后,连续多次 HIV-1 RNA 血浆浓度(病毒载量,VL)低于检测下限)不太可能具有传染性。那么问题就出现了:鉴于历史上采取的措施,VL 的不可检测性有多可靠?哪些因素决定了可靠性?

方法

我们评估了在 2003 年至 2007 年间继续接受 HAART 的瑞士 HIV 队列研究的 6168 名患者中,当第 n 次 VL<50 拷贝/mL 时,第 n+1 次 VL 超过 50 或 1000 HIV-1 RNA 拷贝/mL 的概率(下文称为可靠性)。使用广义估计方程分析了可靠性的潜在因素。

结果

当截止值为 50 拷贝/mL 时,可靠性为 84.5%(n=1),增加到 94.5%(n=5)。依从性、当前的 HAART 类型以及首次接受的抗逆转录病毒治疗(是否接受 HAART)是可靠性的预测因素。当截止值为 1000 拷贝/mL 时,可靠性为 97.5%(n=1),增加到 99.1%(n=4)。通过图表审查发现,在这些情况下,72.2%的患者停止了治疗,承认依从性存在严重问题或正在服用非 HAART 抗逆转录病毒药物。发现 5.6%的病例存在耐药引起的病毒逃逸。在 22.2%的病例中,图表中没有找到解释。

结论

经过多次 VL<50 拷贝/mL 后,当截止值为 50 拷贝/mL 时,可靠性约为 94%,当截止值为 1000 拷贝/mL 时,可靠性约为 99%。依从性是预测可靠性的最重要因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验